🇺🇸 FDA
Patent

US 9029509

Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)

granted A61KA61K2039/505A61K47/646

Quick answer

US patent 9029509 (Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)) held by The Regents of the University of California expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K47/646, A61P, A61P35/00